Division of Cell Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
Department of Biology/Chemistry, University of Osnabrück, Osnabrück, Germany.
EMBO J. 2019 Aug 1;38(15):e101433. doi: 10.15252/embj.2018101433. Epub 2019 May 27.
Cellular homeostasis requires the ubiquitin-dependent degradation of membrane proteins. This was assumed to be mediated exclusively either by endoplasmic reticulum-associated degradation (ERAD) or by endosomal sorting complexes required for transport (ESCRT)-dependent lysosomal degradation. We identified in Saccharomyces cerevisiae an additional pathway that selectively extracts membrane proteins at Golgi and endosomes for degradation by cytosolic proteasomes. One endogenous substrate of this endosome and Golgi-associated degradation pathway (EGAD) is the ER-resident membrane protein Orm2, a negative regulator of sphingolipid biosynthesis. Orm2 degradation is initiated by phosphorylation, which triggers its ER export. Once on Golgi and endosomes, Orm2 is poly-ubiquitinated by the membrane-embedded "Defective in SREBP cleavage" (Dsc) ubiquitin ligase complex. Cdc48/VCP then extracts ubiquitinated Orm2 from membranes, which is tightly coupled to the proteasomal degradation of Orm2. Thereby, EGAD prevents the accumulation of Orm2 at the ER and in post-ER compartments and promotes the controlled de-repression of sphingolipid biosynthesis. Thus, the selective degradation of membrane proteins by EGAD contributes to proteostasis and lipid homeostasis in eukaryotic cells.
细胞内稳态需要依赖泛素的膜蛋白降解。这被认为是通过内质网相关降解(ERAD)或内体分选复合物所需的运输(ESCRT)依赖性溶酶体降解来介导的。我们在酿酒酵母中鉴定出了另一种途径,该途径可以选择性地在高尔基体和内体处提取膜蛋白,以供细胞质蛋白酶体降解。这种内体和高尔基体相关降解途径(EGAD)的一种内源性底物是内质网驻留膜蛋白 Orm2,它是鞘脂生物合成的负调节剂。Orm2 的降解是由磷酸化启动的,磷酸化触发其 ER 输出。一旦在高尔基体和内体上,Orm2 就被嵌入膜中的“固醇调节元件结合蛋白切割缺陷”(Dsc)泛素连接酶复合物多泛素化。然后,CDC48/VCP 将多泛素化的 Orm2 从膜中提取出来,这与 Orm2 的蛋白酶体降解紧密偶联。因此,EGAD 可防止 Orm2 在 ER 和 ER 后区室中的积累,并促进鞘脂生物合成的受控去抑制。因此,EGAD 通过选择性降解膜蛋白有助于真核细胞的蛋白质稳态和脂质稳态。